It could go to .20 -.30 range without FDA approval too. Just with more buying and holding, especially if the float is locked up, this could happen as fast as a week or so. I speculate the company wants it there before the split, so post split it will be in the dollars. Then with strong hands in control it can go over $2 either with FDA approval whenever that may be or the quarterly earnings report in November. Then they can strive for up listing, then big institutional investing will kick in and before you know it this stock will be pushing $6! :)
News 
Market Data 
Discover 
